Cardinal Health, Inc. $CAH Shares Bought by Florida Financial Advisors LLC

Florida Financial Advisors LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,203 shares of the company’s stock after purchasing an additional 2,643 shares during the quarter. Cardinal Health makes up about 0.8% of Florida Financial Advisors LLC’s investment portfolio, making the stock its 28th biggest position. Florida Financial Advisors LLC’s holdings in Cardinal Health were worth $3,213,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in CAH. Aventura Private Wealth LLC purchased a new position in Cardinal Health during the fourth quarter worth about $25,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the 4th quarter valued at about $26,000. Bank of Jackson Hole Trust purchased a new stake in Cardinal Health in the 4th quarter valued at about $27,000. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Finally, Palladiem LLC acquired a new position in shares of Cardinal Health during the 4th quarter valued at about $28,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $225.76 on Tuesday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21. The stock has a market capitalization of $52.88 billion, a P/E ratio of 34.52, a PEG ratio of 1.12 and a beta of 0.49. The stock has a 50-day simple moving average of $217.11 and a 200-day simple moving average of $213.94.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts predict that Cardinal Health, Inc. will post 10.77 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st were given a $0.5158 dividend. The ex-dividend date of this dividend was Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.50%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. decreased their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. TD Cowen upped their price target on shares of Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a report on Friday, May 1st. William Blair started coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Finally, Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $250.07.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.